Peter O. Kwiterovich
The Johns Hopkins Medical Institutions
Baltimore
MD 21287
USA
Name/email consistency: high
- Interrelationships between the concentration and size of the largest high-density lipoprotein subfraction and apolipoprotein C-I in infants at birth and follow-up at 2-3 months of age and their parents. Kwiterovich, P.O., Virgil, D.G., Chu, A.Y., Khouzami, V.A., Alaupovic, P., Otvos, J.D. J. Clin. Lipidol (2013)
- Universal screening of cholesterol in children. Kwiterovich, P.O., Gidding, S.S. Clin. Cardiol (2012)
- Primary and secondary disorders of lipid metabolism in pediatrics. Kwiterovich, P.O. Pediatr. Endocrinol. Rev (2008)
- Recognition and management of dyslipidemia in children and adolescents. Kwiterovich, P.O. J. Clin. Endocrinol. Metab. (2008)
- Cut points for lipids and lipoproteins in children and adolescents: should they be reassessed?. Kwiterovich, P.O. Clin. Chem. (2008)
- A large high-density lipoprotein enriched in apolipoprotein C-I: a novel biochemical marker in infants of lower birth weight and younger gestational age. Kwiterovich, P.O., Cockrill, S.L., Virgil, D.G., Garrett, E.S., Otvos, J., Knight-Gibson, C., Alaupovic, P., Forte, T., Zhang, L., Farwig, Z.N., Macfarlane, R.D. JAMA (2005)
- Lipoprotein heterogeneity at birth: influence of gestational age and race on lipoprotein subclasses and Lp (a) lipoprotein. Kwiterovich, P.O., Virgil, D.G., Garrett, E.S., Otvos, J., Driggers, R., Blakemore, K., Cockrill, S.L., Macfarlane, R.D. Ethn. Dis (2004)
- Response of obligate heterozygotes for phytosterolemia to a low-fat diet and to a plant sterol ester dietary challenge. Kwiterovich, P.O., Chen, S.C., Virgil, D.G., Schweitzer, A., Arnold, D.R., Kratz, L.E. J. Lipid Res. (2003)
- Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. Kwiterovich, P.O., Vining, E.P., Pyzik, P., Skolasky, R., Freeman, J.M. JAMA (2003)
- Lipoprotein heterogeneity: diagnostic and therapeutic implications. Kwiterovich, P.O. Am. J. Cardiol. (2002)
- Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity. Kwiterovich, P.O. Am. J. Cardiol. (2002)
- Safety and efficacy of treatment of children and adolescents with elevated low density lipoprotein levels with a step two diet or with lovastatin. Kwiterovich, P.O. Nutr. Metab. Cardiovasc. Dis (2001)